Discontinued — last reported Q4 '23
Pharmaceutical — Revenue
Cardinal Health Pharmaceutical — Revenue increased by 4.9% to $53.52B in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $47.67B to $53.52B. Over 2 years (FY 2021 to FY 2023), Pharmaceutical — Revenue shows an upward trend with a 14.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher revenue indicates strong market demand and effective distribution volume, though it must be balanced against margin pressures.
Detailed definition
This metric captures the total gross sales generated from the distribution of branded, generic, and specialty pharmaceut...
Peer comparison
Highly comparable to other major pharmaceutical wholesalers who report revenue based on product distribution volume.
cah_segment_pharmaceutical_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $38.34B | $39.82B | $41.38B | $40.96B | $43.34B | $45.83B | $47.67B | $46.81B | $49.70B | $51.01B | $53.52B |
| QoQ Change | — | +3.9% | +3.9% | -1.0% | +5.8% | +5.7% | +4.0% | -1.8% | +6.2% | +2.6% | +4.9% |
| YoY Change | — | — | — | — | +13.0% | +15.1% | +15.2% | +14.3% | +14.7% | +11.3% | +12.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's pharmaceutical — revenue?
- Cardinal Health (CAH) reported pharmaceutical — revenue of $53.52B in Q4 2023.
- How has Cardinal Health's pharmaceutical — revenue changed year-over-year?
- Cardinal Health's pharmaceutical — revenue increased by 12.3% year-over-year, from $47.67B to $53.52B.
- What is the long-term trend for Cardinal Health's pharmaceutical — revenue?
- Over 2 years (2021 to 2023), Cardinal Health's pharmaceutical — revenue has grown at a 14.2% compound annual growth rate (CAGR), from $145.80B to $190.01B.
- What does pharmaceutical — revenue mean?
- The total dollar amount of pharmaceutical products sold by the segment to its customers.